Ulla Puistola

3.8k total citations
112 papers, 2.7k citations indexed

About

Ulla Puistola is a scholar working on Molecular Biology, Cancer Research and Reproductive Medicine. According to data from OpenAlex, Ulla Puistola has authored 112 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 35 papers in Cancer Research and 33 papers in Reproductive Medicine. Recurrent topics in Ulla Puistola's work include Ovarian cancer diagnosis and treatment (24 papers), Cancer, Lipids, and Metabolism (16 papers) and Protease and Inhibitor Mechanisms (15 papers). Ulla Puistola is often cited by papers focused on Ovarian cancer diagnosis and treatment (24 papers), Cancer, Lipids, and Metabolism (16 papers) and Protease and Inhibitor Mechanisms (15 papers). Ulla Puistola collaborates with scholars based in Finland, United States and Sweden. Ulla Puistola's co-authors include Taina Turpeenniemi‐Hujanen, Peeter Karihtala, Antti Kauppila, Kari I. Kivirikko, Saila Kauppila, Leila Risteli, Arja Jukkola‐Vuorinen, Juha Risteli, Lars Rönnberg and Anna Westerlund and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Ulla Puistola

110 papers receiving 2.6k citations

Peers

Ulla Puistola
Ulla Puistola
Citations per year, relative to Ulla Puistola Ulla Puistola (= 1×) peers Beata Smolarz

Countries citing papers authored by Ulla Puistola

Since Specialization
Citations

This map shows the geographic impact of Ulla Puistola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulla Puistola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulla Puistola more than expected).

Fields of papers citing papers by Ulla Puistola

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulla Puistola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulla Puistola. The network helps show where Ulla Puistola may publish in the future.

Co-authorship network of co-authors of Ulla Puistola

This figure shows the co-authorship network connecting the top 25 collaborators of Ulla Puistola. A scholar is included among the top collaborators of Ulla Puistola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulla Puistola. Ulla Puistola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ahtikoski, Anne, et al.. (2024). Redox-state-regulating enzymes have prognostic value in diabetic endometrial cancer patients: impact of statin use?. Frontiers in Oncology. 14. 1393103–1393103. 2 indexed citations
2.
Paavonen, Jorma, et al.. (2023). Immunological Markers ofChlamydia trachomatisInfection in Epithelial Ovarian Cancer. Anticancer Research. 43(9). 4037–4043. 2 indexed citations
3.
Sund, Reijo, Martti Arffman, Ulla Puistola, et al.. (2020). Association of Metformin, Other Antidiabetic Medications, and Statins With Incidence of Colon Cancer in Patients With Type 2 Diabetes. Clinical Colorectal Cancer. 20(2). e113–e119. 3 indexed citations
4.
Arffman, Martti, Reijo Sund, Pirjo Ilanne‐Parikka, et al.. (2018). Antidiabetic Medication, Statins and the Risk and Prognosis of Non-endometrioid Endometrial Cancer in Women with Type 2 Diabetes. Anticancer Research. 38(7). 4169–4178. 10 indexed citations
5.
Marttila, M., Martti Arffman, Reijo Sund, et al.. (2017). Cause-specific mortality in endometrioid endometrial cancer patients with type 2 diabetes using metformin or other types of antidiabetic medication. Gynecologic Oncology. 147(3). 678–683. 10 indexed citations
6.
Puistola, Ulla, et al.. (2016). Remote Ischemic Preconditioning Reduces Cerebral Oxidative Stress Following Hypothermic Circulatory Arrest in a Porcine Model. Seminars in Thoracic and Cardiovascular Surgery. 28(1). 92–102. 9 indexed citations
7.
Karihtala, Peeter, et al.. (2009). DNA Adduct 8-Hydroxydeoxyguanosine, a Novel Putative Marker of Prognostic Significance in Ovarian Carcinoma. International Journal of Gynecological Cancer. 19(6). 1047–1051. 60 indexed citations
8.
Kuoppala, Tapio, Johanna Mäenpää, Eija Tomás, et al.. (2008). Surgically Staged High-Risk Endometrial Cancer: Randomized Study of Adjuvant Radiotherapy Alone vs. Sequential Chemo-Radiotherapy. Obstetrical & Gynecological Survey. 63(11). 703–704. 4 indexed citations
9.
Anttila, Maarit, Taina Turpeenniemi‐Hujanen, Ulla Puistola, et al.. (2007). Prognostic Significance of Extracellular Matrix Metalloproteinase Inducer and Matrix Metalloproteinase 2 in Epithelial Ovarian Cancer. Tumor Biology. 28(5). 280–289. 35 indexed citations
10.
Saarnio, Juha, Hannu Haapasalo, Jyrki Kivelä, et al.. (2006). Expression of transmembrane carbonic anhydrases IX and XII in ovarian tumours. Histopathology. 49(6). 594–602. 80 indexed citations
11.
Kuoppala, Tapio, Arto Leminen, Jorma Penttinen, et al.. (2006). Surgical treatment of ovarian cancer in different hospital categories – A prospective nation-wide study in Finland. European Journal of Cancer. 42(3). 388–395. 33 indexed citations
12.
Talvensaari‐Mattila, Anne, Taina Turpeenniemi‐Hujanen, & Ulla Puistola. (2005). Matrix metalloproteinase 9 and relapse in patients with early stage squamous cervical carcinoma. International Journal of Gynecology & Obstetrics. 91(1). 75–76. 5 indexed citations
13.
Santala, Markku, Leila Risteli, Ulla Puistola, Juha Risteli, & Antti Kauppila. (1995). Elevated Serum ICTP Concentrations Reflect Poor Prognosis in Patients with Ovarian Carcinoma. Annals of Medicine. 27(1). 57–61. 15 indexed citations
14.
Turpeenniemi‐Hujanen, Taina, Ronald F. Feinberg, Antti Kauppila, & Ulla Puistola. (1995). Extracellular matrix interactions in early human embryos: implications for normal implantation events. Fertility and Sterility. 64(1). 132–138. 49 indexed citations
15.
Tomás, Candido, Ulla Puistola, Leila Risteli, Juha Risteli, & Antti Kauppila. (1993). Effect of gynecological operations on the serum concentration of the aminoterminal propeptide of type III procollagen. Acta Obstetricia Et Gynecologica Scandinavica. 72(5). 391–395. 1 indexed citations
16.
Turpeenniemi‐Hujanen, Taina, Lars Rönnberg, Antti Kauppila, & Ulla Puistola. (1992). Laminin in the human embryo implantation: analogy to the invasion by malignant cells. Fertility and Sterility. 58(1). 105–113. 46 indexed citations
17.
Martikainen, Hannu, Lars Rönnberg, Ulla Puistola, et al.. (1989). Prolactin suppression by bromocriptine stimulates aromatization of testosterone to estradiol in women. Fertility and Sterility. 52(1). 51–54. 5 indexed citations
18.
Kauppila, Antti, et al.. (1988). Hypoprolactinemia and ovarian function. Fertility and Sterility. 49(3). 437–441. 38 indexed citations
19.
Martikainen, Hannu, Lars Rönnberg, Ulla Puistola, et al.. (1986). Comparison of the effects of follicle-stimulating hormone and human menopausal gonadotropin on peripheral serum and follicular fluid hormones during ovarian stimulation. Fertility and Sterility. 46(2). 317–320. 8 indexed citations
20.
Puistola, Ulla, Tuula Salo, Hannu Martikainen, & Lars Rönnberg. (1986). Type IV collagenolytic activity in human preovulatory follicular fluid. Fertility and Sterility. 45(4). 578–580. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026